Neuronetics, Inc.
STIM
Rank in Stocks
#17497
Neuronetics, Inc. functions as a medical technology enterprise with... Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.
Share Price
$2.18
Last synced: 2026-11-09
Market Cap
$166.11M
Change (1 day)
1.40%
Change (1 year)
-0.91%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Neuronetics, Inc. (STIM)
Category
Healthcare
Operating Margin for Neuronetics, Inc. (STIM)
Operating Margin as of November 2026 TTM: -14.74%
According to Neuronetics, Inc.'s latest financial reports, its current operating margin (TTM) is -14.74%. At the end of 2025 the company had an operating margin of -21.08%.
Operating Margin history for Neuronetics, Inc. from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -14.74% | -30.08% |
| 2025 | -21.08% | -54.32% |
| 2024 | -46.15% | 7.78% |
| 2023 | -42.82% | -20.48% |
| 2022 | -53.85% | 8.07% |
| 2021 | -49.83% | 10.00% |
| 2020 | -45.30% | 5.40% |
| 2019 | -42.98% | 14.37% |
| 2018 | -37.58% | 11.65% |
| 2017 | -33.66% | 23.39% |
| 2016 | -27.28% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -101.03% |
US
|
|
| 18.08% | -101.23% |
IE
|
|
| 21.25% | -101.44% |
US
|
|
| 21.05% | -101.43% |
US
|
|
| 28.09% | -101.91% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Neuronetics, Inc.'s operating margin
What is Neuronetics, Inc.'s operating margin?
Neuronetics, Inc.'s operating margin is -14.74%, as of Nov 2026.
What was Neuronetics, Inc.'s operating margin in 2025?
In 2025, Neuronetics, Inc.'s operating margin was -21.08%, compared with -46.15% in 2024.
How has Neuronetics, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Neuronetics, Inc.'s operating margin was highest in 2025 (-21.08%) and lowest in 2022 (-53.85%).
How does Neuronetics, Inc.'s operating margin compare with similar companies?
Neuronetics, Inc.'s operating margin (-14.74%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.